Cary Austin

Speaker
Genentech, Inc.

Disclosure information not submitted.

Presentation(s):

• 7 - Research Pathology in Drug R&D and Biotech

  Saturday, April 2, 2022
  8:30 AM – 11:00 AM

• 7.2 - Targeting Kallikrein-Related Peptidases as a Therapeutic Strategy for Netherton’s Syndrome and Atopic Dermatitis

  Saturday, April 2, 2022
  8:30 AM – 9:00 AM